JP Morgan Chase’s Wright Medical Group, Inc. Contingent Value Right WMGIZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-97
Closed – – 6220
2018
Q4
$0 Hold
97
– – ﹤0.01% 6084
2018
Q3
$0 Hold
97
– – ﹤0.01% 5944
2018
Q2
$0 Hold
97
– – ﹤0.01% 5811
2018
Q1
$0 Hold
97
– – ﹤0.01% 5755
2017
Q4
$0 Hold
97
– – ﹤0.01% 5685
2017
Q3
$0 Hold
97
– – ﹤0.01% 5331
2017
Q2
$0 Hold
97
– – ﹤0.01% 5396
2017
Q1
$0 Hold
97
– – ﹤0.01% 5346
2016
Q4
$0 Sell
97
-74
-43% -$98 ﹤0.01% 5246
2016
Q3
$0 Buy
+171
New +$231 ﹤0.01% 4974
2016
Q1
– Sell
-133
Closed – – 5088
2015
Q4
$0 Buy
+133
New +$135 ﹤0.01% 4874

Other funds holding WMGIZ

JP Morgan Chase's WMGIZ Position: Q1 2019 in Review

JP Morgan Chase sold out of Wright Medical Group, Inc. Contingent Value Right (WMGIZ) in Q1 2019, closing a stake of 97 shares.

JP Morgan Chase first reported a position in WMGIZ in Q4 2015 and held it in 11 quarters. The position peaked at $0 in Q4 2018. 2 funds tracked by Wall St. Rank hold WMGIZ as of Q1 2019.

  • JP Morgan Chase reported no remaining Wright Medical Group, Inc. Contingent Value Right position as of Q1 2019 after selling out during the quarter.
  • JP Morgan Chase sold 97 Wright Medical Group, Inc. Contingent Value Right shares in Q1 2019.
  • JP Morgan Chase first reported a position in Wright Medical Group, Inc. Contingent Value Right in Q4 2015 and held it in 11 quarters.
  • JP Morgan Chase's Wright Medical Group, Inc. Contingent Value Right position peaked at $0 in Q4 2018.
  • 2 funds tracked by Wall St. Rank held Wright Medical Group, Inc. Contingent Value Right as of Q1 2019.

Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.